Oct 2026· Frontiers in Immunology· Vol 17· 0 citations· 116 references
Medicine
TL;DR
It is argued that single-cell interrogation of the lupus synovium, a lupus-specific imaging scoring system and a validated imaging-anchored articular outcome measure are the necessary next steps if this manifestation is to be treated with the precision now applied to lupus nephritis.
Abstract
Joint involvement affects the majority of patients with systemic lupus erythematosus and is consistently ranked among the manifestations with the largest impact on daily function, yet lupus synovium remains one of the least interrogated major target tissues in this disease. The primary literature on lupus synovial tissue rests mainly on two datasets, neither generated by single-cell transcriptomic or mass cytometric methods, and what they describe is a relatively pauci-immune and myeloid-dominated compartment carrying an interferon-inducible transcriptional signature in situ, without the ectopic germinal centers and expanded pathogenic fibroblast populations that characterize rheumatoid synovitis. The cell populations now central to systemic lupus biology, among them T peripheral helper cells and double-negative 2 B cells, have never been examined in lupus synovial tissue, so that every cellular account of this compartment remains an extrapolation from rheumatoid arthritis. Recent large-cohort data nevertheless indicate that lupus arthropathy is not a single entity, since non-deforming arthritis and Jaccoud’s arthropathy are both associated with a high type I interferon signature whereas arthritis with clinically irreducible deformity is interferon-low, although whether these represent distinct biological trajectories or successive stages of a single process remains to be established. This heterogeneity is invisible to the instruments used in practice, because the composite indices that grade disease activity and determine eligibility for advanced therapy depend on the detection of joint swelling at the bedside, while musculoskeletal ultrasound and contrast-enhanced magnetic resonance imaging independently demonstrate inflammation in approximately half of patients whose joints appear clinically unremarkable, together with erosive change in patients who lack anti-citrullinated protein antibodies. Misclassification of articular disease is therefore systematic and bidirectional, and the same failure has propagated into drug development, where no recent registrational program has used imaging to define articular response, even though the proportion of patients failing on articular endpoints lies between roughly a third and a half. This review synthesizes the immunopathological, biomarker, imaging and therapeutic literatures, and argues that single-cell interrogation of the lupus synovium, a lupus-specific imaging scoring system and a validated imaging-anchored articular outcome measure are the necessary next steps if this manifestation is to be treated with the precision now applied to lupus nephritis.
Objectives Autoimmune diseases such as primary Sjögren’s disease (pSjD) and systemic lupus erythematosus (SLE) share clinical and serological features, including type I interferon signatures, autoantibody formation, and chronic inflammation, but the underlying immunopathology is not the same. To support the development...
F. Szelinski, Ana-Luisa Stefanski, A. Wiedemann et al.· Frontiers in Immunology· 0 citations
While the systemic lupus erythematosus (SLE), a severe autoimmune disease, is known to relapse frequently after treatment, none of the previous single-cell studies have examined the immune dynamics and their potential contribution to this relapse in the real clinical setting. To address this issue, here we employed sin...
Chen-Rui Xia, J. Qian, Yang Ding et al.· Genomics, Proteomics & Bioin...· 0 citations
OBJECTIVE
Childhood-onset systemic lupus erythematosus (cSLE) is more aggressive than adult SLE, with higher rates of lupus nephritis, organ damage, and early mortality. This review synthesizes recent advances in cSLE genetics and targeted therapies.
METHODS
We conducted a comprehensive literature search in PubMed an...
Autoimmune diseases are characterized by loss of immune tolerance and substantial heterogeneity across patients, tissues, and disease stages. Although bulk transcriptomic studies have identified important inflammatory pathways, they cannot directly resolve rare, transitional, and tissue-contextualized cell states that...
T. Nguyen, T. Nguyễn, O. Hoang et al.· Clinical reviews in allergy...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.